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We have cloned and characterized the Hansenula
polymorpha PEX19 gene. In cells of a pex19 disruption
strain (Hppex19), induced on methanol, peroxisome
structures were not detectable; peroxisomal matrix pro-
teins accumulated in the cytosol, whereas peroxisomal
membrane proteins (PMPs) were mislocalized to the cy-
tosol (Pex3p) and mitochondria (Pex14p) or strongly re-
duced to undetectable levels (Pex10p). The defect in
peroxisome formation in Hppex19 cells was largely
suppressed upon overproduction of HpPex3p or a fusion
protein that consisted of the first 50 N-terminal amino
acids of Pex3p and GFP. In these cells PMPs were again
correctly sorted to peroxisomal structures, which also
harbored peroxisomal matrix proteins. In Saccharomy-
ces cerevisiae pex19 cells overproduction of ScPex3p led
to the formation of numerous vesicles that contained
PMPs but lacked the major matrix protein thiolase.
Taken together, our data are consistent with a function
of Pex19p in membrane protein assembly and function.
Peroxisomes are single membrane-bound organelles that are
present in virtually all eukaryotic cells. The biogenesis and
maintenance of these organelles requires a fine-tuned orches-
tration of various processes, including among others protein
sorting, membrane formation, and organelle fission. During the
last 20 years the knowledge of the principles of peroxisome
formation has rapidly expanded, and over 30 genes (designated
PEX genes) have now been characterized that are involved in
this process (for a recent review see Ref. 1).
Most PEX genes identified so far are required for sorting and
translocation of peroxisomal matrix proteins across the perox-
isomal membrane. Matrix proteins are synthesized in the cy-
tosol and post-translationally imported into peroxisomes. Two
peroxisomal targeting signals (PTS1 and PTS2)1 are known
that are recognized by soluble receptor proteins (Pex5p or
Pex7p, respectively) that sort these proteins to the target or-
ganelle. In the case of peroxisomal membrane proteins (PMPs)
several internal regions have been defined that contain perox-
isomal targeting information (designated mPTS). However,
consensus sequences, like those for matrix proteins, have not
been defined yet. Pex19p has been proposed to play a role as a
general mPTS receptor, but whether this is indeed the case is
still a matter of debate (for a recent review see Ref. 1).
Observations that favor a function of Pex19p as mPTS-
receptor include that, analogous to the PTS receptors for
matrix proteins, in most organisms Pex19p has a dual loca-
tion and is found in the cytosol and, to a minor extent,
associated with peroxisomes (2, 3). Also in line with the
putative mPTS receptor function is the observation that
Pex19p physically interacts with multiple peroxisomal mem-
brane proteins (3–5). Contrary to what may be expected for
an mPTS receptor, Pex19p does not exclusively interact with
the regions of PMPs that contain sorting information for the
peroxisomal membrane. Moreover, mutations are known that
affect targeting of PMPs to the peroxisomal membrane but
not the interaction with Pex19p (2, 5).
The absence of peroxisomal membrane structures is the ex-
pected phenotype of cells lacking a general mPTS receptor.
However, this phenotype may also be explained by a defect in
the formation/assembly of the peroxisomal membrane, result-
ing in the absence of the target membrane for newly synthe-
sized PMPs. Saccharomyces cerevisiae pex19 mutants (6, 7) and
human fibroblasts from patients with defects in PEX19 lack
peroxisomal membrane structures and display significantly re-
duced levels of PMPs that are mislocalized to the cytosol or
other cell organelles (3). However, in Pichia pastoris pex19
cells, small vesicular structures are observed that have been
proposed to represent precursors of peroxisomes (2) and in
Yarrowia lipolytica pex19 cells structures are found that
strongly resemble WT peroxisomes in size, shape, and protein
composition (8). However, these organelles display a major
defect in matrix protein import and reduced levels of PMPs.
To shed further light on a putative generalized function of
Pex19p, we cloned the Hansenula polymorpha PEX19 gene and
analyzed its role in peroxisome biogenesis. In a constructed H.
polymorpha PEX19 disruption strain, peroxisomal structures
were undetectable and PMPs were mislocalized. However, we
observed that peroxisomes could be formed in the absence of
HpPex19p upon overproduction of HpPex3p or the first 50
N-terminal amino acids of this protein, fused to GFP. These
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data suggest that H. polymorpha Pex19p is not essential for
sorting of PMPs. Also in S. cerevisiae pex19 cells peroxisomal
membranes could be reintroduced by overproduction of
ScPex3p. The details of this work are included in this report.
EXPERIMENTAL PROCEDURES
Organisms and Growth—The H. polymorpha, P. pastoris, and S.
cerevisiae strains used in this study are listed in Table I. H. polymorpha
cells were cultivated at 37 °C, P. pastoris and S. cerevisiae at 30 °C.
Yeast cells were grown on 1% yeast extract, 1% peptone, and 1%
glucose, selective minimal media containing 0.67% yeast nitrogen base
without amino acids (Difco) or mineral media (9) supplemented with
glucose (0.5%), methanol (0.5%), or glycerol (0.5%) as carbon source and
methylamine (0.25%) or ammonium sulfate (0.25%) as nitrogen source.
S. cerevisiae cells were grown on yeast nitrogen base containing 0.1%
oleic acid, 0.05% Tween 40, 0.1% yeast extract, and 0.1% glucose. When
required, amino acids or uracil were added to a final concentration of 30
g/ml. For growth on agar plates, the media were supplemented with
1.5% agar. Escherichia coli was grown on LB medium (10), supple-
mented with ampicillin (100 g/ml), or kanamycin (50 g/ml) when
required.
Molecular Techniques—Standard recombinant DNA techniques were
carried out essentially according to Sambrook et al. (10). Primers used
for polymerase chain reactions in this study are listed in Table II.
Transformation of H. polymorpha cells and site-specific integration of
single or multiple copies of plasmid DNA in genomic AOX-, PEX3-, or
AMO-locus was performed as described previously (11–15). For the
replacement of the wild type PEX14 gene with the PEX14-GFP fusion
gene, the plasmid pHIPX10-PEX14eGFPPstI was linearized with
SalI. The plasmid pHOR50 was linearized using BsgI for the integra-
tion into the PEX19-locus.
Isolation and Characterization of the H. polymorpha PEX19 Gene—
P. pastoris pex19 (SKF13) was transformed with an H. polymorpha
genomic library in the P. pastoris vector pYM8 (16). Histidine prototro-
phic transformants were screened for the ability to grow on methanol.
From a selected positive strain the plasmid, designated pHP19-5, was
rescued and transformed to E. coli dH5. To facilitate sequencing,
restriction analysis and construction of subclones, a 2.9-kb DNA frag-
ment obtained from pHP19-5 was subcloned as an NheI-HindIII frag-
ment into HindIII-XbaI-digested phagemid pBluescript II KS (pBSII
KS, Stratagene Inc., San Diego, CA), resulting in pHOR28. Double
strand sequencing was carried out on an ABI 373A automatic sequencer
(Applied Biosystems Inc.) using the Taq Dye Deoxy Terminator Cycle
Sequencing kit. For DNA and amino acid sequence analysis the PC-
GENETM program release 6.70 (IntelliGenetics, Mountain View, CA)
was used. The BLASTN algorithm (17) was used to search the Gen-
BankTM data base (Release 91.0, October 15, 1995) for DNA, and pro-
tein sequences showing similarity to the HpPEX19 gene and its trans-
lation product. The nucleotide sequence of HpPEX19 was deposited at
GenBankTM and was assigned accession number AF176708.
PEX19 Disruption in H. polymorpha—For disruption of the complete
H. polymorpha PEX19 gene the H. polymorpha URA3 gene was used
(18). The URA3 was isolated as a BglII, PstI fragment and ligated
between the two flanking regions of the H. polymorpha PEX19 gene.
These regions were obtained by PCR on pHOR28 using primers RB12
and RB13 containing the sequence upstream the start codon, digested
with BglII and the primers 40 uni  RB11, containing the sequence
downstream the stop codon, digested with PstI. This fragment was used
to transform H. polymorpha NCYC495 leu1.1 ura3. Methanol utiliza-
tion-deficient (Mut) colonies were selected. Correct integration was
analyzed by Southern blotting using the ECL direct nucleic acid label-
ing and detection system (Amersham Biosciences, Arlington Heights,
IL).
Plasmid Constructions—Expression plasmids pHIPX4-PEX3 (14),
pHIPX4-PEX3N50GFP (pFEM75) (19), pHOR46 (15), and pHIPZ5-
PEX3N50GFP (pFEM167) (20) have been described before. pHIPX4-
PEX19 (pHOR32) was constructed as follows. Using PCR and primers
RB16 and RB17 a BamHI site was introduced upstream the start codon,
and a SalI site downstream the stop codon of the H. polymorpha PEX19
gene. These sites were used to clone the PEX19 gene into a BamHI-
SalI-digested pHIPX4 (21).
For localization of HpPex19p, MYC-PEX19 was expressed under
control of the PEX3 promoter. For this plasmid pHIPX6-MYC-PEX19,
MYC-PEX19 was amplified using the primers RB17  RB26, resulting
in a product containing an in-frame fusion between the MYC tag and
the PEX19 gene. This PCR product was then digested with BamHI and
SalI and ligated into the BamHI-SalI digested pHIPX6 (14). A second
construct, used for the localization of HpPex19p, included a hybrid gene
under control of the PEX3 promoter encoding a HpPex19p.GFP fusion
protein (pHIPX6-PEX19-GFP). The green fluorescent protein (GFP,
Clontech) was fused to the C terminus of Pex19p. The PEX19 gene was
amplified using primers 19GFP-start and 19GFP-stop, resulting in a
product lacking the stop codon of the PEX19 gene. This PCR product
was then digested with HindIII and ligated into pANL31 (22), resulting
in plasmid pHIPZ-PEX19-GFP, containing an in-frame fusion of the
whole PEX19 gene fused to the eGFP gene. This product was subse-
quently restricted with BamHI and SmaI, and ligated into a BamHI,
SmaI-digested pHIPX6.
To identify peroxisomes, the gene encoding DsRed-T1-SKL was ex-
pressed under control of the alcohol oxidase promoter (PAOX). A DNA
fragment encoding an in-frame fusion of DsRED-T1 and SKL was
obtained by PCR using primers DsRed-1 and DsRed-2, and a plasmid
TABLE I
Strains used in This study
Strains Relevant properties Reference
H. polymorpha
NCYC495 Wild type, ura3 leu1.1 (45)
pex19::URA3 PEX19 disruption strain, leu1.1 This study
pex19::PPEX19PEX19C286S pex19 with one-copy integration of plasmid pHOR40 This study
pex19::PPEX3PEX19-GFP pex19 containing the plasmid pHIPX6-PEX19-GFP This study
pex19::PPEX3PEX19-GFP::PAODsRED-SKL pex19::PPEX3PEX19-GFP with one-copy integration of plasmid pHIPX4-
DsRED-SKL
This study
pex3::LEU1.1 (ura3) PEX3 disruption strain, ura3 (11)
NCYC495::PAOPEX3N50-GFP (HF74) NCYC495 with one-copy integration of plasmid pFEM75 (19)
pex19::PAOPEX3N50-GFP pex19 with one-copy integration of plasmid pFEM75 This study
pex14::PPEX14PEX14-GFP NCYC495 with one-copy integration of plasmid pHIPX10-
PEX14eGFPPstI
This study
pex19::pex14::PPEX14PEX14-GFP pex19 with one-copy integration of plasmid pHIPX10-PEX14eGFPPstI This study
pex19::pex3::PPEX3PEX3-GFP pex19 with one-copy integration of plasmid pHOR46 This study
pex19::PAOPEX3 pex19 with multicopy integration of plasmid pHIPX4-PEX3 This study
pex3::PAOPEX19 pex3 with multicopy integration of plasmid pHIPX4-PEX19 This study
pex19::PPEX3MYC-PEX19 pex19 containing the plasmid pHIPX6-MYC-PEX19 This study
pex3::pex19::PAMOPEX31–50-GFP pex3, pex19 with one-copy integration of plasmid pFEM167 This study
S. cerevisiae
UTL-7A WT (46)
pex19 PEX19 disruption strain (6)
pex19 Pex13p-tev-ProtA pex19 producing Protein A tagged Pex13p This study
pex19 Pex13p-tev-ProA  pTF14 pex19 Pex13p-tev-ProA overproducing PEX3 (FOX3 promoter in
YEp352)
This study
pex19 Pex13p-tev-ProA  pTF15 pex19 Pex13p-tev-ProA overproducing PEX3 (CTA1 promoter in YEp352) This study
P. pastoris
P. pastoris SKF13 PEX19 disruption strain (2)
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containing DsRed-T1 (23) in-frame fused to HDEL containing a spacer
peptide THGMDELYK, kindly donated by B. Glick. The PCR product
was digested with BamHI and SalI and subsequently ligated in pHIPX4
digested with BamHI and SalI, resulting in plasmid pHIPX4-
DsRed-T1-SKL.
For the construction of a gene encoding Myc-Pex19p containing an
amino acid substitution in the farnesylation site, plasmid pHOR50 was
constructed. For this purpose plasmid pHIPX13, containing the PEX19
promoter, was constructed by amplification of the PEX19 promoter
using primers RB36 and RB37. The PCR product was then ligated as a
NotI-BamHI fragment in pHIPX4, digested with NotI and BamHI. For
the plasmid pHOR40 the PEX19 gene was amplified using primers
RB26 and RB18, resulting in a product containing an N-terminal myc-
tagged HpPex19p with an amino acid substitution (C286S) at the C
terminus. The PCR product was then digested with BamHI and SalI
and inserted into BamHI-SalI-digested pHIPX13.
For the localization of HpPex14p, a plasmid encoding a fusion protein
consisting of HpPex14p containing GFP at the C terminus was con-
structed. This was performed by digestion of pHIPX10-PEX14eGFP,
kindly donated by M. Komori (Osaka Prefecture University, Osaka,
Japan), with PstI. This resulted in plasmid pHIPX10-PEX14eGFPPstI.
S. cerevisiae strains, containing genomic copies of a hybrid ScPEX13
gene encoding ScPex13p fused to the tobacco etch virus protease cleav-
age site followed by a Protein A tag (TEV-ProtA) were obtained by
transforming haploid yeast cells with the corresponding PCR product
according to Knop et al. (24). Scpex19 strains overproducing ScPEX3
were obtained by transforming Scpex19 with plasmid pTF14 (expres-
sion plasmid containing ScPEX3 under control of the FOX3 promoter)
or pTF15 (expression plasmid containing PEX3 under control of the
CTA1 promoter). Cloning strategies and sequences of primers used to
make pTF14 and pTF15 are available upon request.
Biochemical Methods—Crude extracts of H. polymorpha cells were
prepared as described by Baerends et al. (19). Subcellular fractionation
of H. polymorpha cells was performed as detailed before (25) except that
a modified sucrose gradient was used consisting of 4 ml of 65%, 9 ml of
50%, 9 ml of 40%, and 4 ml of 35% (w/v)-sucrose in buffer B (5 mM MES,
0.1 mM EDTA, 1 mM KCl, pH 5.5). Flotation centrifugation of H. poly-
morpha fractions was carried out according to Goodman et al. (26).
S. cerevisiae cells were fractionated by differential centrifugation.
Cells were converted to spheroplasts using zymolyase (20 units/g cells).
Spheroplasts were washed three times in a solution containing 1.2 M
sorbitol and homogenized in 0.6 M sorbitol in 5 mM MES, pH 6.0,
supplemented with 0.5 mM EDTA and 1 mM KCl (fractionation buffer).
Intact cells and nuclei were removed from the homogenate by two
centrifugation steps at 600  g for 10 min. The resulting post nuclear
supernatant (T) was further fractionated by differential centrifugation
resulting in a 25,000  g pellet, 25,000  g supernatant, 100,000  g
pellet, and a 100,000  g supernatant. Pellet fractions were resus-
pended in fractionation buffer. Equivalent volumes of these fractions
were analyzed by SDS-PAGE and immunoblotting.
Enzyme activities of alcohol oxidase (27) and cytochrome c oxidase
(28) were assayed as described. Protein concentrations were determined
using the Bio-Rad Protein Assay system (Bio-Rad GmbH, Munich,
Germany) using bovine serum albumin as standard.
SDS-PAGE (29) and native gel electrophoresis (30) was carried out as
described. Western blotting was performed as detailed by Kyhse-
Andersen (31). Blots were decorated using specific antibodies against
various proteins using either the Protoblot immunoblotting system
(Promega Biotec) or a BM Chemiluminescence Western blotting kit
(Roche Applied Science, Almere, The Netherlands). Polyclonal antibod-
ies against HpPex19p were raised in rabbit, using synthetically syn-
thesized HpPex19p peptides (amino acids 1–15 and 194–208).
Fluorescence Correlation Spectroscopy—HpPex19.GFP present in
soluble and membrane fractions of methanol-grown H. polymorpha
pex19::PPEX3PEX19-GFP cells was analyzed by fluorescence correlation
spectroscopy (FCS). H. polymorpha cells that did not produce
HpPex19.GFP were used as controls. Cells were harvested by centrif-
ugation, resuspended in buffer A (50 mM Tris-HCl, pH 7.0, containing
300 mM NaCl, 10% glycerol, 0.1 mM phenylmethylsulfonyl fluoride, and
CompleteTM protease inhibitor mixture), and broken using a French
pressure cell. The cell lysate was centrifuged for 1 h at 100,000  g
(4 °C) and resulted in a soluble fraction (designated S), which was used
for FCS measurements. The pellet (P) was washed once in buffer A and
subsequently resuspended in buffer A containing 1% digitonine to sol-
ubilize membrane proteins, followed by centrifugation at 100,000  g
for 1 h (4 °C). The supernatant, representing the solubilized membrane
protein fraction (designated P), was also used for FCS measurements.
The ConfoCor2 (Zeiss the Netherlands BV, Weesp, The Netherlands),
a dual channel system based on a Zeiss Axiovert 100M inverted micro-
scope, was used to acquire fluorescence fluctuation data. The system is
equipped with an argon ion laser line of 488 nm and a 40  1.2 water
immersion apochromatic objective and is controlled by AIM3.1 software
(EMBL Heidelberg, Germany). The system was calibrated by optimiz-
FIG. 1. Levels of peroxisomal matrix proteins and peroxins in
chemostat-grown H. polymorpha pex19 cells relative to wild
type levels. Western blots were prepared of crude extracts and deco-
rated with antibodies against H. polymorpha amine oxidase (AMO),
alcohol oxidase (AO), catalase (CAT), Pex3p, Pex5p, Pex10p, and
Pex14p. The levels of all proteins were similar in both strains, except for
Pex10p, which was below the level of detection in Hppex19 cells.
TABLE II
Primers used in This study
Primers Sequence
RB12 CCC AGA TCT TGA AAA GTT TCT AAA CCC
RB13 GGG GTC GAC TTT TGC AAG TGA TTC
RB11 GGG CTG CAG TTA TGG TTA ATA TGA GCG
40 uni (Stratagene) GTT TTC CCA GTC ACG AC
RB16 TAA GGA TCC ATG AGC GAG AAA AAG TCC G
RB17 CTT TGT CGA CCT ATG TTT GTT TGC AAG TG
RB18 CCC TGT CGA CCT ATG TTT GTT TAC TAG TGT CTT CCA GTT C
RB26 GGG GGA TCC ATG GAG CAG AAG TTG ATT TCT GAG GAA GAC TTG AGC GAG AAA AAG TCC G
RB36 GAG GCG GCC GCG GTT CTT GTG GAT TCG AC
RB37 GGG GGA TCC TTA TGG TTA ATA TGA GCG
19GFP-start CCC AAG CTT ATG AGC GAG AAA AAG TCC G
19GFP-stop GTG TTT GTT TGC AAG TGT CTT CC
DsRED-1 AGA GGA TCC ATG GCC TCC TCC GAG GAC G
DsRED-2 AGA GTC GAC TTA CAG CTT CGA CTT GTA CAA TTC GTC CAT ACC
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ing the position of the pinhole and the correction ring of the objective
lens using a solution of 5 nM Alexa Fluor 488 (Molecular Probes, Leiden,
The Netherlands). Samples were measured in 96-well plates. Autocor-
relation traces were acquired during 10 or 20 s at room temperature
and repeated 20 times. Autocorrelation curves were globally analyzed
to multicomponent three-dimensional Brownian motion models, which
included triplet kinetics using the FCS data processor 1.3 software (the
Scientific Software Technologies Center of Belarusian State University,
Belarus) as detailed before (32–34).
Microscopy—Fluorescence microscopy was performed as described
before (19). Confocal laser scanning microscopy on living cells was
carried out using a Zeiss LSM 510 META-NLO confocal laser scanning
microscope (Zeiss, the Netherlands BV) equipped with a Zeiss plan-
apochromatic 63 numerical aperture 1.4 objective. GFP fluorescence
was analyzed by excitation of the cells with a 488-nm argon/krypton
laser, and fluorescence was detected by a BP 500–550 Photo Multiplier
Tube (PMT). Whole cells were treated for 10 min at 37 °C with 50 g/ml
Hoechst 33258 (Sigma, Nieuwegein, The Netherlands) to stain nuclei.
Mitochondria were stained by incubation of intact cells for 30 min at
37 °C with 0.5 g/ml MitoTracker Red Cm-H2XROS (Molecular Probes)
followed by extensive washing with medium.
Cells incubated with Hoechst 33258 were analyzed using excitation
at 760 nm (Ti-Sapphire laser) and detection by a BP 435- to 485-nm
PMT. Cells treated with MitoTracker were excited at 543 nm (He laser),
and fluorescence was detected using a BP 565- to 615-nm PMT.
Whole cells were fixed and prepared for electron microscopy and
immunocytochemistry as described previously (35). Immunolabeling
was performed on ultrathin sections of Unicryl-embedded cells, using
specific antibodies against various proteins and gold-conjugated goat-
anti-rabbit antibodies, or goat-anti-mouse antibodies (35).
RESULTS
Cloning of the H. polymorpha PEX19 Gene—A P. pastoris
PEX19 disruption strain was functionally complemented by
transformation with an H. polymorpha genomic library. The
plasmid, recovered from complemented P. pastoris cells, con-
tained an open reading frame encoding a protein with high
homology to Pex19 proteins (e.g. 41% identity to P. pastoris
Pex19p). Also, it contained the typical Pex19p farnesylation
site (-CKQT) at the extreme C terminus. To further substanti-
ate that the cloned gene represented H. polymorpha PEX19, a
disruption strain (Hppex19) was constructed. Cells of this
strain were unable to grow on methanol, which is characteristic
for H. polymorpha PEX mutants (36). Based on these findings
we concluded that the cloned gene represented HpPEX19. The
sequence of the complementing DNA fragment was deposited
at GenBankTM (accession number AF176708).
To characterize the peroxisome phenotype of Hppex19 cells
in detail, the cells were grown in a glucose-limited chemostat
using choline as sole nitrogen source. These conditions result in
massive peroxisome proliferation and strong induction of per-
oxisome matrix and membrane proteins in WT cells (37). West-
ern blot analysis of crude cell extracts revealed that the levels
of the matrix proteins alcohol oxidase (AO), catalase (CAT), and
amine oxidase (AMO) were similar in WT and Hppex19 cells
(Fig. 1). Also the peroxisomal membrane proteins (PMPs)
HpPex3p and HpPex14p as well as the PTS1 receptor Pex5p
were detected at similar levels in both strains. However, the
level of the integral PMP HpPex10p was strongly reduced in
Hppex19 cells and below the limit of detection.
Electron microscopy studies revealed that peroxisomes or
peroxisomal remnant structures (ghosts) were not detectable in
Hppex19 cells (Fig. 2A). Immunocytochemistry demonstrated
that the matrix proteins AO, CAT, AMO, and dihydroxyacetone
synthase (DHAS) were mislocalized to the cytosol (see Fig. 2B
for AO). Using specific antisera against PMPs, -HpPex3p-
specific labeling was observed on the cytosol, whereas
-HpPex14p-dependent labeling was confined to discrete spots
on mitochondrial profiles (data not shown).
The presence of cytosolic HpPex3p and the localization of
HpPex14p at mitochondria was confirmed by fluorescence mi-
croscopy (Fig. 2, C–E). To this purpose Hppex19 strains were
constructed in which the authentic HpPEX3 gene was replaced
by an HpPEX3.GFP hybrid gene (pex19.pex3::PPEX3PEX3-
GFP), or the HpPEX14 gene was replaced by an HpPEX14.GFP
hybrid gene (pex19.pex14::PPEX14PEX14.GFP). Both fusion pro-
teins are fully functional, because they functionally comple-
ment the pex phenotype of H. polymorpha pex3 (15) and pex14
cells, respectively (data not shown).
The mislocalization of HpPex3p and HpPex14p were also
demonstrated by biochemical analyses using sucrose density
centrifugation of post-nuclear supernatants prepared from che-
mostat-grown cells (Fig. 3A). Analysis of the various fractions
obtained demonstrated that no protein peak was observed at a
density of 52% sucrose, the position where peroxisomes of WT
cells normally sediment (25). AO, HpPex3p, and minor
amounts of HpPex14p were present in the upper fractions of
the gradient, where soluble cytosolic proteins are located,
whereas the bulk of HpPex14p and a minor amount of HpPex3p
FIG. 2. Morphological analysis of
Hppex19 cells. In ultrathin sections of
KMnO4-fixed, chemostat-grown cells (A)
peroxisomal structures were not detecta-
ble. Immunolabeling experiments revealed
that the matrix proteins AO and DHAS
were mislocalized to the cytosol and nu-
cleus (B, AO; DHAS not shown). Fluores-
cence microscopy showed that in Hppex19
cells HpPex3p.GFP is localized to the cy-
tosol (D). C, bright-field picture. Analysis
by confocal laser scanning microscopy (E)
indicated that HpPex14p.GFP (green) is
present in a single spot on mitochondria
(visualized in red by MitoTracker). In this
latter figure the cell is not visualized. The
bar in A and B represents 0.5 m. N,
nucleus; M, mitochondrion; V, vacuole.
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co-fractionated with mitochondria (fractions 13–15, Fig. 3A). To
further substantiate that the bulk of the HpPex14p is bound to
mitochondria, whereas HpPex3p is predominantly soluble,
their respective peak fractions of the sucrose gradient were
subjected to flotation centrifugation. Upon flotation centrifuga-
tion of the HpPex14p peak fractions (fractions 13–15, Fig. 3B),
HpPex14p protein migrated to the upper part of the gradient to
the same position as the mitochondrial marker protein malate
dehydrogenase (38). The minor amounts of HpPex3p present in
these fractions behaved similarly. These results are consistent
with the microscopy findings that bulk of the HpPex14p is
mislocalized to mitochondria in Hppex19 cells. In identical
experiments using the HpPex3p peak fractions (fractions 17
and 18, Fig. 3A), HpPex3p remained at the bottom of the
gradient upon flotation centrifugation (Fig. 3C), indicating that
the bulk of this protein was not membrane-bound.
Overproduction of HpPex3p Restores Peroxisome Formation
in Hppex19 Cells—The mislocalization of PMPs in Hppex19
cells may have multiple causes and be the result of a defect in
PMP sorting or alternatively caused by the absence of the
normal target membrane. To distinguish between the two lat-
ter possibilities we aimed to introduce peroxisomal membrane
vesicles in Hppex19 cells. This approach was based on earlier
findings in Hppex3 cells that also lack peroxisomal membrane
structures, but in which peroxisomal membrane vesicles are
formed upon production of a fusion protein consisting of the
first 50 amino acids of HpPex3p and GFP (HpPex3pN50.GFP)
(20). This N-terminal part of HpPex3p contains peroxisomal
targeting information. Hence, when HpPex3pN50.GFP is pro-
duced in wild type cells, this protein is properly sorted to
peroxisomes (20) (Fig. 4A).
First, we analyzed whether the formation of peroxisomal
membrane vesicles in Hppex3 cells was dependent on the func-
tion of HpPex19p. To this end, we produced HpPex3pN50.GFP
under control of the amine oxidase promoter (PAMO) in a con-
structed pex3.pex19 double disruption strain. As shown in Fig.
4C, fluorescent spots were detected in these cells in the vicinity
of the nuclei, similar to that observed in Hppex3 cells synthe-
sizing HpPex3pN50.GFP and representing membrane vesicles
(20). This suggests that HpPex19p is not required for the for-
mation of these membrane vesicles. Subsequently, we produced
HpPex3pN50.GFP in Hppex19 cells. Methanol-induced cells of
this strain showed relatively large, bright fluorescent spots
when observed by fluorescence microscopy (Fig. 4B). Electron
microscopic analysis of KMnO4-fixed cells demonstrated that
these cells contained peroxisome-like structures that were re-
duced in size relative to WT peroxisomes (data not shown).
Immunocytochemistry revealed that the HpPex3pN50.GFP fus-
ing protein was localized at the membranes of these structures
together with HpPex3p and HpPex14p (Fig. 5). In similar ex-
periments using antibodies against the major peroxisomal ma-
trix proteins, we found that these structures contained a sig-
nificant fraction of AO and DHAS but not CAT protein (Fig. 5).
Cell fractionation (Fig. 6) and flotation experiments (data not
shown) confirmed that in these cells the PMPs HpPex3p and
HpPex14p co-sedimented again and were membrane-associ-
ated. However, as in Hppex19, the level of HpPex10p was below
the level of detection (Fig. 6B).
When instead of Pex3pN50.GFP full-length HpPex3p was
overproduced in Hppex19 (pex19::PAOXPEX3), peroxisomal
structures were also detected in the cells (data not shown).
Partial suppression of the peroxisome-deficient phenotype was
not observed when Pex19p was overproduced in Hppex3 cells
(pex3::PAOXPEX19). In such cells peroxisomes or peroxisomal
remnant structures could not be detected (data not shown).
These data are consistent with the hypothesis that mislocal-
FIG. 3. Subcellular fractionation of Hppex19::pex14::PPEX14-
PEX14.GFP cells. A postnuclear supernatant prepared from chemostat-
grown cells was subjected to sucrose density centrifugation. A, protein (E)
and sucrose (dotted line) concentrations, mitochondrial cytochrome c oxi-
dase activities (Œ) peroxisomal AO activities (f). The panel below shows
Western blots of fractions 5–22 decorated with the indicated antibodies.
HpPex3p and HpPex14p have different locations. B, a flotation analysis of
the pooled HpPex14p peak fractions of the sucrose gradient (fractions
13–15); C, the flotation analysis of the fractions (17 and 18), which con-
tained the bulk of HpPex3p. The fractions of the flotation gradients were
analyzed by Western blotting using the indicated antibodies. MDH, mi-
tochondrial marker protein malate dehydrogenase. Protein concentra-
tions are indicated as mg.ml1, sucrose concentrations as % (w/w). En-
zyme activities are expressed as percentages of the activity in the peak
fractions, which were arbitrarily set to 100. For Western blots equal
portions of the fractions were loaded per lane.
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ization of HpPex3p and HpPex14p in pex19 cells is most likely
due to the absence of their normal target membrane rather
than the result of a defect in PMP targeting.
Overproduction of ScPex3p in S. cerevisiae pex19 Cells Re-
sults in Peroxisomal Membrane Formation—To analyze
whether the data depicted above are unique for H. polymorpha
or also valid in other yeast, we overproduced full-length
ScPex3p in an S. cerevisiae PEX19 disruption strain (Scpex19)
(6). To this end a strain was constructed that contained
ScPEX3 under control of a strong promoter (PFOX3 or PCTA1).
Electron microscopy revealed the presence of high numbers of
vesicular structures in these cells (Fig. 7, B and C) that were
absent in Scpex19 controls (Fig. 7A). These membranes con-
tained ScPex3p as evident from immunocytochemistry (Fig.
7D), but not thiolase (not shown), which remained mislocalized
in the cytosol of these cells.
The stability and localization of PMPs in the S. cerevisiae
strains was also analyzed biochemically. To facilitate the de-
tection of ScPex13p, strains producing an ScPex13p-Protein A
fusion protein were used (24). Cell fractionation experiments
revealed that in WT controls ScPex13p and ScPex3p were
predominantly present in the organellar pellet fractions
(25,000  g pellet, Fig. 8) upon differential centrifugation of a
postnuclear supernatant. In the absence of ScPex19p the levels
of both proteins were strongly reduced and below the level of
detection at normal exposure times of the Western blots. Using
prolonged exposure times (Fig. 8, asterisk), it became evident
that most of the remaining ScPex3p and ScPex13p fractions
were soluble in Scpex19 cells (25,000  g and 100,000  g
supernatants, Fig. 8A), but became pelletable again upon over-
production of ScPex3p (25,000  g pellet, Fig. 8). At the same
time the level of ScPex13p increased again, suggesting that
this PMP was stabilized upon overproduction of ScPex3p. Flo-
tation analysis confirmed that ScPex3p and ScPex13p were
indeed membrane-bound again in Scpex19 cells overproducing
ScPex3p (data not shown).
HpPex19p.GFP Localization—To analyze the subcellular lo-
cation of HpPex19p, polyclonal antibodies were raised against
HpPex19p. Using these antibodies, we were unable to detect a
cross-reacting protein band on Western blots prepared from
crude extracts of methanol-grown H. polymorpha WT cells. We
therefore constructed a strain that expressed the PEX19 gene
under control of the weak PEX3 promoter. A Myc tag was fused
to the N terminus of HpPex19p to be able to detect the protein
with commercially available monoclonal anti-Myc antibodies as
well (strain pex19::PPEX3Myc-PEX19). Cells of this strain grew
normally on methanol, indicating that the Myc-tagged Pex19p
was functional. In crude extracts of methanol-grown cells of
this strain a protein band with an apparent molecular mass of
47 kDa was detected using anti-Pex19p (Fig. 9A) or anti-myc
(not shown) antibodies. However, in fractions of sucrose gradi-
ents prepared from these cells, the protein remained undetect-
able, probably because it is unstable or susceptible to proteo-
lytic degradation.
We then aimed to localize HpPex19p by fluorescence micros-
copy. The constructed strain pex19::PPEX3PEX19-GFP was ca-
pable of growing on methanol and formed normal peroxisomes,
indicating that HpPex19p.GPF is functional (data not shown).
Fluorescence microscopy of methanol-grown cells of this strain
revealed that fluorescence was present in the cytosol and en-
hanced at the periphery of peroxisomes, which were character-
ized by red fluorescence due to the incorporation of the red
fluorescent protein DsRed (DsRed-SKL, Fig. 9B).
HpPex19p.GFP Is a Component of Large Complexes Both in
the Cytosol and at Membranes—Whether HpPex19p is an
mPTS receptor that binds to newly synthesized PMPs in the
cytosol or functions as a chaperone is still a matter of debate.
To analyze the presence of putative PMP-HpPex19p protein
complexes, we analyzed HpPex19p.GFP by fluorescence corre-
lation spectroscopy (FCS) and native gel electrophoresis in
soluble and membrane fractions of crude cell extracts.
FCS is a technique that allows the measurement of diffusion
constants of fluorophores, which allows then the estimation of
their molecular weight (32). Whole cells synthesizing
HpPex19p.GFP were broken, and membranes (P) were sepa-
rated from the soluble fraction (S). The membrane fraction was
subsequently solubilized by digitonin followed by centrifuga-
FIG. 4. Localization of HpPex3pN50.GFP by fluorescence microscopy. HpPex3pN50.GFP was synthesized in WT (A), Hppex19 (B), and the
pex3 pex19 double mutant (C). Overlays of bright-field and fluorescence pictures are shown. In WT control cells, HpPex3pN50.GFP is sorted to the
peroxisomal membrane, resulting in fluorescent spots that consist of clusters of peroxisomes. In Hppex19 cells (B) and cells of the pex3 pex19 double
mutant (C), fluorescent spots are also evident. These spots are generally formed in the vicinity of the nucleus, which is visualized by Hoechst 33258
(blue; C, inset).
FIG. 5. Peroxisome structures are formed in Hppex19 cells
producing Pex3pN50.GFP. Ultrathin sections of chemostat-grown
Hppex19::PAOXPEX3N50.GFP cells were used for immunolabeling exper-
iments. These experiments revealed that the peroxisomal matrix pro-
tein AO (A) and DHAS (C) are present both in peroxisomes and in the
cytosol, whereas peroxisomal catalase was fully mislocalized to the
cytosol (E). Anti-GFP labeling revealed that HpPex3pN50.GFP was pres-
ent at the peroxisomal membranes (B), where HpPex3p (D) and
HpPex14p (F) are located as well. The bars represent 0.5 m. P, per-
oxisome; M, mitochondrion; N, nucleus; V, vacuole.
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tion to remove insoluble material. P and S fractions obtained
from cells lacking the HpPex19p.GFP fusion protein were used
as controls. Normalized fluorescence autocorrelation curves of
samples P and S were fitted globally to a diffusion model,
including triplet kinetics (see “Experimental Procedures”).
In fraction P (Fig. 10A), the best fit was achieved when a
one-component diffusion model was used. Using the equation,
MW1  (1/2)
3  MW2, the molecular mass of the
HpPex19p.GFP-containing complex was estimated to be 253
kDa (confidence limit, 206–360 kDa). Similar data were ob-
tained when fraction S was analyzed by FCS (data not shown)
and the size of this complex was similar (estimated molecular
mass of 243 kDa; confidence limits of 142–318 kDa). These
data suggest that either HpPex19p may form homotetramers
in both fractions (the calculated molecular mass of the
HpPex19p.GFP fusion protein is 60 kDa) or alternatively, one
or more proteins may be bound to a single HpPex19p-GFP
molecule resulting in a protein complex with the total mass of
250 kDa. In control samples prepared of cells that did not
produce HpPex19.GFP, no fluorescence fluctuations that could
be autocorrelated were observed.
Native gel electrophoresis experiments confirmed the pres-
ence of large HpPex19p.GFP-containing protein complexes in
the P and S fractions. Upon Western blot analysis using anti-
GFP antibodies, both in the P and S fractions the most domi-
nant band was located 250 kDa (Fig. 10B), which is in the
same range as the size of the complexes predicted by FCS. In
control cells lacking GFP, no cross-reacting bands were found,
indicating that the observed bands are due to specific binding
of the anti-GFP antibodies to the GFP fusion protein.
Although similar bands are found in both fractions, this is
not due to contamination of the membrane fraction with solu-
FIG. 6. HpPex3p and HpPex14p co-
localize at peroxisomal structures
in Hppex19 cells producing Pex3pN50.
GFP. A, a postnuclear supernatant pre-
pared from homogenized, chemostat-
grown pex19::PAOXPEX3N50-GFP cells
was subjected to sucrose density centrifu-
gation. The graph shows the protein (f)
and sucrose concentrations (dotted line)
as well as the activities of cytochrome c
oxidase (Œ) and AO (F). Protein concen-
trations are expressed as mg.ml1, su-
crose concentrations as % (w/w), enzyme
activities as percentages of the activity
in the peak fractions, which were arbi-
trary set at 100. The fractions of the
gradient were analyzed by Western blot-
ting using the indicated antibodies.
Equal portions of the fractions were
loaded per lane. B, Western blots using
crude cell extracts of WT (lane 1), Hppex-
19 cells (lane 2), and Hppex19::PAOX-
PEX3N50-GFP (lane 3), showing the vir-
tual absence of HpPex10p in the mutant
cells.
FIG. 7. Morphological analysis of S. cerevisiae pex19 cells over-
producing ScPex3p. In ultrathin sections of KMnO4-fixed Scpex19 cells
overproducing ScPex3p (Scpex19 plus pTF14) numerous small vesicular
structures are visible in the cytosol (B and C), which were absent in
Scpex19 control cells (A). C shows a magnification of the indicated region
in B. Immunolabeling experiments using anti-ScPex3p antibodies re-
vealed that these vesicles contained ScPex3p (D). The bars represent 0.5
m (A and B) or 0.1 m (C and D). M, mitochondrion; N, nucleus.
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ble proteins or vice versa. This is based on the results obtained
with control blots, which revealed that the membrane marker
protein HpPex3p was only detected in fraction P, whereas the
soluble marker protein pyruvate carboxylase was confined to
the soluble fraction (S; data not shown). Taken together, our
data suggest that HpPex19p.GFP is predominantly present in
protein complexes of 250 kDa.
Fusion of an Myc tag or GFP to the C terminus of HpPex19p
disables farnesylation at the C-terminal farnesylation site of
the protein (-CKQT). Our finding that both fusion proteins are
fully functional, therefore, indicates that HpPex19p farnesyla-
tion is not essential for peroxisome formation. This was con-
firmed by the observation that cells producing a mutant form of
HpPex19p in which the farnesylation site is inactivated
(pex19::PPEX19PEX19C286S) also grew on methanol and
formed peroxisomes (data not shown).
DISCUSSION
Here we report the cloning and characterization of the H.
polymorpha PEX19 gene. PEX19 genes have been identified in
several organisms, ranging from yeast to human, and encode
hydrophilic proteins with a consensus sequence for farnesyla-
tion (1). A distinct role for Pex19p farnesylation has not been
established yet. Also in H. polymorpha Pex19p we observed
that farnesylation is not essential for its function in peroxisome
biogenesis.
Fluorescence microscopy revealed that HpPex19p.GFP has a
dual location and is present in the cytosol and at the peroxi-
some periphery. Similar observations have been made for other
Pex19ps and led to the hypothesis that Pex19p may be a shut-
tling mPTS receptor by analogy to the receptors of peroxisomal
matrix proteins, Pex5p and Pex7p (1).
Two-hybrid studies revealed that Pex19ps of various organ-
isms interacted with multiple membrane proteins (4–5).
Whether these interactions occur predominantly in the cytosol
or at the peroxisomal membrane is still unclear. Human
Pex19p (HsPex19p) has been shown to interact preferentially
with newly synthesized PMPs in the cytosol, a finding that
favors a function as mPTS receptor (3). However, by using
fluorescence resonance energy transfer analysis, Muntau et al.
(39) recently concluded that the interaction of HsPex3p and
HsPex19p predominantly occurs at the peroxisomal mem-
brane. Snyder et al. (4) reported that PpPex19p predominantly
interacts with pre-existing PMPs at the peroxisomal mem-
brane. At this location Pex19p may have a chaperone-like role
for instance in facilitating PMP insertion/assembly.
Our native gel electrophoresis and FCS studies revealed that
under steady-state conditions the bulk of the HpPex19p.GFP is
present in relatively large protein complexes of 250 kDa both
in soluble and membrane-bound fractions. This seems to con-
tradict the observation that Pex19ps interact with a large
number of different PMPs, which would result in a range of
Pex19p-PMP complexes of various sizes. However, these may
be transient and, therefore, below the limit of detection.
Interestingly, an additional role for cytosolic rat Pex19p was
proposed recently in internalization of a sodium-dependent
phosphate co-transporter (40). Therefore, a portion of the cyto-
solic Pex19p in rat may function in another cellular process
than peroxisome biogenesis, a phenomenon that deserves fur-
ther attention in yeast research.
In most organisms studied so far, the levels of PMPs are
strongly reduced in cells lacking Pex19p. In S. cerevisiae pex19
cells the minor amounts of PMPs that remain are present in
the cytosol, where they are rapidly degraded (7). Some PMPs
are mislocalized to mitochondria in the absence of Pex19p (e.g.
Pex14p in human fibroblasts (3)). Most likely these PMPs har-
bor cryptic sorting signals, which localize them to mitochondria
when peroxisomal membranes are absent.
We show that the levels of HpPex3p and HpPex14p are not
affected by the absence of HpPex19p in H. polymorpha cells, a
finding that greatly facilitated the analysis of their location
(HpPex3p, cytosol; HpPex14p, mitochondria). However, the
level of HpPex10p was strongly reduced and below the level of
detection.
In general, PMP mislocalization in peroxisome-deficient cells
can be related to defects in their sorting or insertion/assembly
machineries. Sorting defaults could, e.g., result from improper
mPTS recognition (e.g. due to a defect in the mPTS receptor).
Also, the targeting mechanisms could still be functional, but
not effective, because of defaults in PMP insertion/assembly (4,
8) or defects in the formation of the peroxisomal lipid bilayer.
In this report we showed that the absence of peroxisomal
membranes and the mislocalization of PMPs in H. polymorpha
pex19 could be largely suppressed by overproduction of the first
50 amino acids of Pex3p fused to GFP (Pex3N50.GFP) or full-
length HpPex3p. In these cells peroxisomal structures were
present that, based on biochemical and ultrastructural criteria,
are peroxisomes and contained peroxisomal matrix and mem-
brane proteins. These findings indicate that in the absence of
HpPex19p PMPs apparently can be correctly sorted to peroxi-
somal membranes and the peroxisomal lipid bilayer can be
formed. It is therefore unlikely that HpPex19p is the general
mPTS receptor in H. polymorpha. Also, it is unlikely that
FIG. 8. Overproduction of ScPex3p in S. cerevisiae pex19 cells
affects the protein level and sedimentation behavior of Pex13p.
Postnuclear supernatants (T) were prepared from oleic acid-induced
cells of the indicated strains and subjected to differential centrifugation
(two successive centrifugation steps at 25,000  g (25) and 100,000  g
(100)). S, supernatant; P, pellet. All strains produced Protein A-tagged
Pex13p. The fractions were analyzed by Western blotting using IgGs to
decorate Protein A in the Pex13p-ProteinA fusion protein (A) or anti-
Pex3p antibodies (B). Equal portions of each fraction were loaded per
lane except for the 100,000  g pellet fraction, of which 10 times more
protein was loaded. UTL-7A, WT S. cerevisiae; pTF14, overexpression of
ScPEX3 under control of the FOX3 promoter; pTF15, overexpression of
ScPEX3 under control of the CTA1 promoter. *, prolonged exposure to
visualize the protein bands.
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HpPex19p is essential for the formation of the peroxisomal
lipid bilayer.
The peroxisomal structures that are formed in Hppex19 cells
producing Pex3N50.GFP contain a significant portion of the
major matrix proteins. Therefore the membranes of these or-
ganelles apparently contain some functional protein complexes
FIG. 9. Localization of HpPex19p. A, a Western blot decorated with anti-HpPex19p antibodies. Equal amounts of crude extracts of
trichloroacetic acid-precipitated, methanol-grown cells were used. WT, wild type H. polymorpha; 	19, Hppex19::PPEX3Myc-PEX19. Only in the
blots of the latter strains was Pex19p visualized. B, fluorescence microscopy of cells that produce HpPex19p.GFP (green fluorescence, left panel).
Fluorescence is evident in the cytosol and at the peroxisomal edges. DsRed-SKL is used to visualize peroxisomes (DsRed-SKL, red fluorescence,
middle panel). The right panel shows an overlay of bright-field, green fluorescence, and red fluorescence images.
FIG. 10. HpPex19p.GFP is present in large complexes, both in the cytosol and at the peroxisomal membrane. A, examples of
experimental autocorrelation curves, fitted curves, and residuals (upper inset) of FCS experiments using solubilized membrane fraction of whole
cells producing HpPex19p.GFP. After global analysis of 20 experimental curves, a diffusion time of 243 s was obtained (confidence limit: 226–272
s). Based on these data the calculated molecular mass of the fluorescent protein complex is estimated to amount 253 kDa (confidence limit:
206–360 kDa) assuming that the complex is globular in shape. B, a Western blot of a native gel loaded with solubilized membrane (P) or soluble
fraction (S) of the same cells (Pex19-GFP) or controls cells that do not produce Pex19-GFP (control). The blots were decorated with anti-GFP
antibodies. Both fractions contain a dominant band with an apparent molecular mass of 250 kDa.
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able to facilitate matrix protein import. This observation does
not exclude a function for HpPex19p in the efficient formation
of functional PMP complexes. Possibly, in the absence of
HpPex19p non-functional PMP complexes exist, which may
explain why peroxisome formation and matrix protein import is
not fully restored. Indeed, the level of HpPex10p remained
extremely low in these cells, which may be one of the reasons
for the partial import defect of the major matrix proteins and
the complete defect of catalase import.
Also in Y. lipolytica pex19 cells, which still contain peroxiso-
mal structures, the levels of both PMPs tested (YlPex2p and
YlPex16p) were significantly reduced compared with WT cells
(8). This suggests that, in this organism also, PMPs are still
correctly targeted to peroxisomal membranes but failed to pro-
duce fully functional protein complexes (e.g. those involved in
matrix protein import (41, 42)), a phenomenon that may be
related to the fact that YlPex2p and YlPex16p are instable.
A similar reasoning may explain why in Scpex19 cells that
overproduce ScPex3p matrix protein import are not restored.
Nevertheless, in these cells membranes are formed that con-
tain ScPex3p and ScPex13p. In conclusion, our data are con-
sistent with a role of Pex19ps in the formation of functional
membrane protein complexes rather than in PMP sorting or
formation of the peroxisomal lipid bilayer.
A specific characteristic of cells defective in Pex19p is that
their respective peroxisome phenotypes differ strongly, varying
from the complete absence of peroxisome structures (e.g. in
mammalian cells and S. cerevisiae) to the presence of normal
peroxisomal structures (in Y. lipolytica). Our data in H. poly-
morpha may add to an explanation of these puzzling differ-
ences. Obviously, one option is that these differences are re-
lated to specific species differences. However, in H. polymorpha
pex19, we can largely mimic the various above phenotypes by
controlling the levels of HpPex3p, ranging from complete ab-
sence of peroxisomes (normal HpPex3p levels) to the presence
of peroxisomes (HpPex3p or Pex3N50.GFP overproduction).
Previous data from Faber et al. (20) demonstrated that small
peroxisomal vesicles can be formed from the nuclear envelope
in Hppex3 cells upon synthesis of Pex3N50.GFP, structures that
can develop into normal peroxisomes. Comparable observa-
tions have been made in Y. lipolytica (43). We showed that a
comparable process also occurred with H. polymorpha in the
absence of HpPex19p and resulted in the formation of peroxi-
somes in Hppex19 cells. Based on these observations we hy-
pothesize that peroxisome formation from the endomembrane
system is almost completely blocked in S. cerevisiae, H. poly-
morpha, and mammalian cells defective in Pex19p but regu-
larly occurring in Y. lipolytica pex19. An intermediate situation
is observed in P. pastoris, which contains small vesicular struc-
tures in the absence of Pex19p. We speculate that the absence
or presence of peroxisomal structures may be related to futile
differences in PMP and/or peroxin levels, differences that may
even be related to changes in cultivation conditions or, in
higher eukaryotes, dependent on tissue and developmental
stage (44). These minor differences may explain why in certain
organisms the peroxisomal structures are absent in the ab-
sence of Pex19p, but readily detectable in others.
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